Use of Historical Marker Data for Assessing Treatment Effects in Phase I/II Trials When Subject Selection is Determined by Baseline Marker Level

DOI10.2307/2533004zbMath0875.62498OpenAlexW2320181930WikidataQ36679993 ScholiaQ36679993MaRDI QIDQ4335731

Michael D. Hughes, Hung-Mo Lin

Publication date: 9 November 1997

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2533004

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (2)

Estimation of the Correlation Between Nutrient Intake Measures Under Restricted Sampling ⋮ Adjusting for Regression Effect in Uncontrolled Studies

This page was built for publication: Use of Historical Marker Data for Assessing Treatment Effects in Phase I/II Trials When Subject Selection is Determined by Baseline Marker Level